Our Products
Our Services
Explore how Sai Parenterals Ltd.’s IPO performed on its first day of subscription, including investor participation, price band details, key dates, and the step-by-step process to apply through ASBA or UPI.
The Sai Parenterals Ltd. IPO opened for subscription on March 24, 2026, marking its debut in the Indian primary market. The company operates in the pharmaceutical segment, focusing on manufacturing and distribution of healthcare products.
The IPO is a book-built issue with a price band of ₹372 to ₹392 per share, aiming to raise approximately ₹408.79 crore. The issue opened with limited initial traction across investor categories.
The IPO saw a slow start on its opening day, with minimal participation from most investor segments.
On the first day of bidding, the Sai Parenterals Ltd. IPO recorded an overall subscription of 0.03×, reflecting subdued investor interest.
| Investor Category | Subscription (Times) |
|---|---|
Qualified Institutional Buyers (QIB) |
N.A. |
Retail Individual Investors (RII) |
0.01× |
Non-Institutional Investors (NII) |
0.02× |
Others |
N.A. |
Total |
0.03× |
The Day 1 data indicates muted participation across all categories, with only marginal bids from retail and non-institutional investors. Institutional participation is yet to pick up, which may influence the overall momentum in the coming days.
On the second day of bidding, the Sai Parenterals Ltd. IPO showed a slight improvement in subscription levels, reaching an overall subscription of 0.06×.
| Investor Category | Subscription (Times) |
|---|---|
Qualified Institutional Buyers (QIB) |
0.60× |
Retail Individual Investors (RII) |
0.05× |
Non-Institutional Investors (NII) |
1.05× |
Total |
0.42× |
The Day 2 data indicates gradual participation from all investor segments, with non-institutional investors leading the subscription, though overall demand remains modest.
The IPO price band is set between ₹372 and ₹392 per share, with a face value of ₹5 per share
Investors can apply for a minimum of 1 lot consisting of 38 shares..
| Investor Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
Retail (Minimum) |
1 |
38 |
₹14,896 |
At the upper price band, the minimum investment required is approximately ₹14,896, making it accessible for retail investors.
For detailed insights about the company, issue particulars, and the latest updates, visit the Sai Parenterals IPO on Bajaj Markets.
Here are the key IPO dates:
| Event | Date | Details |
|---|---|---|
IPO Open Date |
March 24, 2026 |
Issue opens for subscription |
IPO Close Date |
March 27, 2026 |
Final day to submit bids |
Basis of Allotment |
March 30, 2026 |
Allotment finalisation |
Refunds Initiation |
April 1, 2026 |
Refunds begin |
Credit of Shares to Demat |
April 1, 2026 |
Shares credited |
Listing Date |
April 2, 2026 |
Expected listing on exchanges |
Note: These dates represent procedural milestones based on publicly available data and are intended for informational purposes only.
The information provided above is based on publicly available data from reliable financial news and market sources. Investors are advised to verify figures and consult financial experts before making investment decisions. Market conditions and subscription numbers are subject to change during the IPO window.
Sources
LiveMint — IPO News and Updates, https://www.livemint.com/market/ipo
Economic Times — IPO News: Latest IPO News, Upcoming IPO, https://economictimes.indiatimes.com/markets/ipo
Financial Express — IPO News, https://www.financialexpress.com/market/ipo-news/
NDTV Profit — IPOs, https://www.ndtvprofit.com/ipos
Business Today — IPO Corner: Latest IPO News & Analysis, https://www.businesstoday.in/markets/ipo-corner
Anshika brings 7+ years of experience in stock market operations, project management, and investment banking processes. She has led cross-functional initiatives and managed the delivery of digital investment portals. Backed by industry certifications, she holds a strong foundation in financial operations. With deep expertise in capital markets, she connects strategy with execution, ensuring compliance to deliver impact.
Anshika
Anshika
Anshika
Anshika
Anshika
Anshika
Nupur Wankhede
Nupur Wankhede
Nupur Wankhede
Roshani Ballal
Nupur Wankhede
Anshika
Nupur Wankhede
Nupur Wankhede
Nupur Wankhede
Nupur Wankhede
Nupur Wankhede
Nupur Wankhede
Nupur Wankhede
Geetanjali Lachke
Nupur Wankhede
Nupur Wankhede
Anshika
Anshika
Geetanjali Lachke
Anshika
Anshika
Anshika
Anshika
Anshika
Anshika
Anshika
Anshika
Nupur Wankhede
Roshani Ballal
Nupur Wankhede
Anshika
Nupur Wankhede
Geetanjali Lachke
Geetanjali Lachke
Geetanjali Lachke
Anshika
Nupur Wankhede
Nupur Wankhede
Anshika
Anshika
Nupur Wankhede
Nupur Wankhede
Nupur Wankhede
Nupur Wankhede
Geetanjali Lachke
Nupur Wankhede
Anshika
Nupur Wankhede
Anshika
Nupur Wankhede
Geetanjali Lachke
Anshika
Anshika
Roshani Ballal
Anshika
Nupur Wankhede
Nupur Wankhede
Nupur Wankhede
Anshika
Roshani Ballal
Anshika
Nupur Wankhede
Anshika
Anshika
Anshika
Anshika
Geetanjali Lachke
Anshika
Nupur Wankhede
Nupur Wankhede
Nupur Wankhede
Anshika
Anshika
Anshika
Anshika
Anshika
Anshika
Anshika
Anshika
Roshani Ballal
Anshika
Anshika
Nupur Wankhede
Nupur Wankhede
Nupur Wankhede
Anshika
Nupur Wankhede
Anshika
Anshika
Anshika
Anshika
Roshani Ballal
Geetanjali Lachke
Geetanjali Lachke
Geetanjali Lachke
Geetanjali Lachke
Geetanjali Lachke
Roshani Ballal
Roshani Ballal